The ageing population and increased demand for healthcare products and services across the globe are creating great opportunities for businesses in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. At the same time the delivery of global healthcare is changing fast and creating significant opportunities for private providers.

At Clearwater International we have the knowledge, experience, track record and reach to help companies exploit these growing global opportunities. Given these dynamics it’s a market which remains a rich source of M&A deal flow and corporate activity as private providers take advantage of outsourcing opportunities and investors seek to consolidate market positions. Our sector team works closely with innovative companies who are at the forefront of the healthcare revolution, advising businesses on their strategies for dealing with governments seeking to drive efficiencies and improve patient experiences.


Sector Comments

Healthcare sector comment: Increasing R&D expenditure driving the global CRO market

The global contract research organisation (CRO) services market is expected to reach $56.3bn (€46.6bn) by 2023, a rise from $39.1bn (€32.3bn) in 2018, demonstrating a CAGR of 7.6%1. The key drivers behind this growth includes; an increase in R&D expenditure … Find out more…

Healthcare sector comment: Cosmetic surgery

The global cosmetic surgery market is reported to be worth $21.97bn (€18.8bn) by the end of 2023, and projected to grow at a CAGR of ~7.8% during 2017-20231. This market growth is driven by the rising desire to look youthful. … Find out more…

Healthcare sector comment: A look back at 2017

2017 saw 2011 deals complete, with Q2 showing the strongest performance with 29.4%, followed by Q1 with 27.6%, Q3 with 24.1% and Q4 with 18.9%. The majority of these deals were in the health and social care sub-sector with 56.3%, … Find out more…